PRHSX: T. Rowe Price Health Sciences

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

PRHSX T. Rowe Price Health Sciences


Profile

PRHSX - Profile

Vitals

  • YTD Return 5.8%
  • 3 Yr Annualized Return 7.9%
  • 5 Yr Annualized Return 1.3%
  • Net Assets $13.4 B
  • Holdings in Top 10 35.1%

52 WEEK LOW AND HIGH

$86.18
$60.38
$86.41

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.76%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 38.80%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $2,500
  • IRA $1,000

Fund Classification


Distributions

  • YTD Total Return 5.8%
  • 3 Yr Annualized Total Return 7.9%
  • 5 Yr Annualized Total Return 1.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.00%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    T. Rowe Price Health Sciences Fund
  • Fund Family Name
    T. Rowe Price
  • Inception Date
    Dec 29, 1995
  • Shares Outstanding
    N/A
  • Share Class
    No Load
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Ziad Bakri

Fund Description

The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Fund Company Quick Screens

PRHSX - Fund Company Quick Screens


Performance

PRHSX - Performance

Return Ranking - Trailing

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.8% -10.4% 13.2% 33.08%
1 Yr 18.9% -13.8% 33.5% 50.00%
3 Yr 7.9%* -12.5% 25.7% 27.03%
5 Yr 1.3%* -11.2% 10.8% 26.21%
10 Yr 12.5%* -1.4% 17.4% 11.90%

* Annualized

Return Ranking - Calendar

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
2019 21.5% 5.7% 55.4% 37.61%
2018 -4.7% -25.3% 21.5% 33.33%
2017 19.1% -10.8% 43.9% 43.12%
2016 -14.2% -31.6% 6.9% 47.17%
2015 1.3% -20.4% 13.8% 21.78%

Total Return Ranking - Trailing

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.8% -10.4% 13.2% 33.08%
1 Yr 18.9% -13.8% 33.5% 50.00%
3 Yr 7.9%* -12.5% 29.0% 36.94%
5 Yr 1.3%* -11.2% 13.8% 56.31%
10 Yr 12.5%* -1.4% 19.0% 46.43%

* Annualized

Total Return Ranking - Calendar

Period PRHSX Return Category Return Low Category Return High Rank in Category (%)
2019 21.5% 5.7% 55.4% 37.61%
2018 -4.7% -25.3% 22.2% 41.44%
2017 19.1% -10.8% 45.8% 55.96%
2016 -14.2% -26.4% 8.7% 58.49%
2015 1.3% -16.6% 15.2% 61.39%

NAV & Total Return History


Holdings

PRHSX - Holdings

Concentration Analysis

PRHSX Category Low Category High PRHSX % Rank
Net Assets 13.4 B 1.97 M 45.8 B 3.08%
Number of Holdings 139 28 387 8.46%
Net Assets in Top 10 3.77 B 141 K 16.9 B 3.85%
Weighting of Top 10 35.06% 21.6% 78.5% 78.46%

Top 10 Holdings

Asset Allocation

Weighting Return Low Return High PRHSX % Rank
Stocks
96.64% 58.15% 100.11% 54.62%
Cash
3.17% 0.00% 41.85% 33.85%
Preferred Stocks
0.20% 0.00% 2.47% 9.23%
Other
0.00% -2.07% 13.00% 93.85%
Convertible Bonds
0.00% 0.00% 0.00% 90.77%
Bonds
0.00% 0.00% 15.06% 90.77%

Stock Sector Breakdown

Weighting Return Low Return High PRHSX % Rank
Healthcare
99.51% 61.99% 100.00% 70.00%
Basic Materials
0.49% 0.00% 2.08% 6.92%
Utilities
0.00% 0.00% 0.00% 90.77%
Technology
0.00% 0.00% 15.32% 94.62%
Real Estate
0.00% 0.00% 6.65% 91.54%
Industrials
0.00% 0.00% 3.92% 90.77%
Financial Services
0.00% 0.00% 1.75% 93.85%
Energy
0.00% 0.00% 0.33% 90.77%
Communication Services
0.00% 0.00% 5.13% 93.85%
Consumer Defense
0.00% 0.00% 34.06% 90.77%
Consumer Cyclical
0.00% 0.00% 1.12% 91.54%

Stock Geographic Breakdown

Weighting Return Low Return High PRHSX % Rank
US
85.06% 49.84% 98.57% 20.77%
Non US
11.58% 0.00% 42.15% 74.62%

Expenses

PRHSX - Expenses

Operational Fees

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.76% 0.10% 9.84% 88.98%
Management Fee 0.64% 0.09% 1.30% 43.85%
12b-1 Fee N/A 0.00% 1.00% 4.17%
Administrative Fee 0.15% 0.03% 0.40% 80.95%

Sales Fees

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

PRHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 38.80% 5.00% 341.00% 55.12%

Distributions

PRHSX - Distributions

Dividend Yield Analysis

PRHSX Category Low Category High PRHSX % Rank
Dividend Yield 0.00% 0.00% 5.10% 90.77%

Dividend Distribution Analysis

PRHSX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

PRHSX Category Low Category High PRHSX % Rank
Net Income Ratio 0.00% -2.24% 2.12% 43.31%

Capital Gain Distribution Analysis

PRHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

PRHSX - Fund Manager Analysis

Managers

Ziad Bakri


Start Date

Tenure

Tenure Rank

Apr 01, 2016

4.08

4.1%

Ziad Bakri joined T. Rowe Price in 2011 and has since been a key member of the healthcare research team, influencing investment decisions and making significant contributions to the stock selections. Ziad has had a long track record of analyzing biotechnology companies, a key sector within the healthcare industry. Ziad brings a unique perspective to his new role, having been a medical doctor and an emergency medicine resident at the Royal London Hospital before beginning his investment career. Prior to joining T. Rowe Price, Ziad held biotechnology equity research and healthcare investment banking analyst positions in other investment firms

Tenure Analysis

Category Low Category High Category Average Category Mode
0.26 22.64 10.09 20.01